
Largest clinical trial for blood cancer that has spread to brain shows new treatment regime dramatically improves survival for some patients
The largest ever clinical trial looking at the best way to treat lymphoma if it…
The largest ever clinical trial looking at the best way to treat lymphoma if it…
Researchers from the The Max Delbrück Center (MDC) for Molecular Medicine in the Helmholtz Association…
This authors of a new paper published in Oncotarget reported that the aim of this study is…
Cutaneous T cell lymphomas (CTCLs) are a group of non-Hodgkin lymphomas that develop from T…
CD58 aberrations limit durable responses to CD19 CAR in large B cell lymphoma patients treated…
A CAR T-cell therapy known as axicabtagene ciloleucel (axi-cel) drove cancer cells to undetectable levels…
The histone deacetylase (HDAC) inhibitor vorinostat (Zolinza) in combination with the mTOR inhibitor sirolimus (Rapamune)…
Skipping radiation and receiving less chemotherapy may become the new standard of care for some…
Targeting a “cell survival” protein could be a valuable new approach to treating certain blood…
Researchers at The University of Texas MD Anderson Cancer Center, USA, have identified molecular and…